Russell Investments Group’s CAMP4 Therapeutics CAMP Stock Holding History

Russell Investments Group’s Portfolio CAMP Stock Details CAMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1K	Buy	+2,529	New	+$10.9K	﹤0.01%	3917

Other funds holding CAMP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Russell Investments Group's CAMP Position: Q2 2026 in Review

Russell Investments Group opened a new position in CAMP4 Therapeutics (CAMP) in Q2 2026: 2,529 shares worth $11.1K. The stake represents ﹤0.01% of the portfolio and ranks #3917 among its holdings.

16 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

Russell Investments Group held 2,529 shares of CAMP4 Therapeutics worth $11.1K as of Q2 2026.
CAMP4 Therapeutics was a new Russell Investments Group position in Q2 2026.
CAMP4 Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3917 holding.
16 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.